Price movement over the last 24 hours
Aehr Test Systems vs Centene Corp — how do they compare? Aehr Test Systems trades at $68.34 (market cap $2.11B), while Centene Corp trades at $66.94 (market cap $32.65B). The key difference: Centene Corp is far larger — about 15.5× Aehr Test Systems's market cap, and Centene Corp is trading nearer its 52-week high, Aehr Test Systems nearer its low. Which is the better fit depends on your goals.
| AEHR | CNC | |
|---|---|---|
Market Cap | $2.11B | $32.65B |
Sector | Technology | Health |
52-Week High | $116.58 | $68.34 |
52-Week Low | $13.29 | $25.21 |
Enterprise Value | $2.08B | $25.28B |
Signals from Pluang's Aura AI — not financial advice
AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.
Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →